Alterations in the glycosylation of serum total
immunoglobulins show these
antibodies to have a diagnostic potential for
cancer but the disease-related Abs to the
tumor-associated
antigens, including
glycans, have still poorly been investigated in this respect. We analysed serum samples from patients with
breast carcinoma (n = 196) and controls (n = 64) for the level of Thomsen-Friedenreich (
TF) antigen-specific antibody isotypes, their sialylation, interrelationships, and the avidity by using ELISA with the synthetic TF-
polyacrylamide conjugate as an
antigen and the
sialic acid-specific Sambucus nigra
agglutinin (SNA) and
ammonium thiocyanate as a chaotrope. An increased sialylation of
IgG and
IgM, but a lower SNA reactivity of
IgA TF
antibodies, and a higher level and avidity of the TF-specific
IgA were found in
cancer patients. Other
cancer-related signatures were the highly significant increase of the
IgG/
IgA ratio and the very low SNA/
IgA index in
cancer, including patients with an early stage of the disease. These changes showed a good diagnostic potential with about 80% accuracy. Thus, the level of naturally occurring anti-
TF antigen antibodies, their sialylation profile, isotype distribution, and avidity displayed
cancer-specific changes that could serve as novel noninvasive Ab-based
biomarkers for early
breast cancer.